TTK HEALTHCARE LIMITED Intrinsic Value
TTKHLTCARE · Diversified · Current price ₹980.45
Is TTK HEALTHCARE LIMITED undervalued?
DocStoX estimates the fair value of TTK HEALTHCARE LIMITED at ₹882 per share, versus the current market price of ₹980. That puts the stock about -10.0% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is medium.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹728), Relative P/E (₹1,119), Graham floor (₹1,011). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹728 (bear) to ₹882 (base) to ₹1,119 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹980 versus an intrinsic value of ₹882, TTK HEALTHCARE LIMITED currently offers -10.0% of negative margin (i.e. a premium).
More on TTK HEALTHCARE LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.